Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262
Hyperglycemic hyperosmolar nonketotic syndrome as initial presentation of type 2 diabetes in a young cocaine abuser. Diabetes Care August 1999 22:1380-1381; doi:10.2337/diacare.22.8.1380
Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347
Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation.
Humalog Mix25 Study Group. Diabetes Care August 1999 22:1258-1261; doi:10.2337/diacare.22.8.1258
Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325
Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and
Complications Trial data. Diabetes Care August 1999 22:1273-1277; doi:10.2337/diacare.22.8.1273
Intensive insulin therapy compared with conventional insulin therapy does not reduce depressive symptoms in parents of children
with type 1 diabetes. Diabetes Care August 1999 22:1372-1373; doi:10.2337/diacare.22.8.1372
Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a
Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325
Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a
Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a
Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318
The European Association for the Study of Diabetes Annual Meeting, 1998: complications of diabetes. Diabetes Care August 1999 22:1364-1370; doi:10.2337/diacare.22.8.1364
Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with
normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339
Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with
normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339
Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371
Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro
insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374
Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting
in subjects with type 1 diabetes. Diabetes Care August 1999 22:1252-1257; doi:10.2337/diacare.22.8.1252
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? Diabetes Care August 1999 22:1384-1385; doi:10.2337/diacare.22.8.1384
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245
Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371
Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Serum gamma-glutamyltransferase and/or serum cholinesterase as markers of the metabolic syndrome. Diabetes Care August 1999 22:1381-1382; doi:10.2337/diacare.22.8.1381
Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262
Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325
Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278
Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330
Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and
Complications Trial data. Diabetes Care August 1999 22:1273-1277; doi:10.2337/diacare.22.8.1273
Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro
insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374
Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278
Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with
normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339
Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and
deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245
Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro
insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371
Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and
deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347
Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a
Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting
in subjects with type 1 diabetes. Diabetes Care August 1999 22:1252-1257; doi:10.2337/diacare.22.8.1252
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized
controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296
Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer. Diabetes Care August 1999 22:1292-1295; doi:10.2337/diacare.22.8.1292
Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized
controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347
Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and
deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378
Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347
Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371
Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Intensive insulin therapy compared with conventional insulin therapy does not reduce depressive symptoms in parents of children
with type 1 diabetes. Diabetes Care August 1999 22:1372-1373; doi:10.2337/diacare.22.8.1372
Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting
in subjects with type 1 diabetes. Diabetes Care August 1999 22:1252-1257; doi:10.2337/diacare.22.8.1252
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized
controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296
Hyperglycemic hyperosmolar nonketotic syndrome as initial presentation of type 2 diabetes in a young cocaine abuser. Diabetes Care August 1999 22:1380-1381; doi:10.2337/diacare.22.8.1380
Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with
normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339
Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245
Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes.
Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245
Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278
Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330
Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262
Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro
insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374
Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325
Sustained improvement of glycemic control by insulin treatment after 9 years in patients with type 2 diabetes and secondary
failure. Diabetes Care August 1999 22:1373-1374; doi:10.2337/diacare.22.8.1373
Association between stress and glycemic control in adults with type 1 (insulin-dependent) diabetes. Diabetes Care August 1999 22:1278-1283; doi:10.2337/diacare.22.8.1278
Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and
deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized
controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296
Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro
insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374
Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes.
Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized
controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296
Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and
deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378
Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care August 1999 22:1284-1291; doi:10.2337/diacare.22.8.1284
Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes.
Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302
Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a
Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and
deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378
Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325
Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and
deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? Diabetes Care August 1999 22:1384-1385; doi:10.2337/diacare.22.8.1384
Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with
normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339
Partial Wolfram syndrome (DIDMOAD): two new patients in a family. Diabetes insipidus, diabetes mellitus, optic atrophy, and
deafness. Diabetes Care August 1999 22:1378-1379; doi:10.2337/diacare.22.8.1378
Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with
normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro
insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374
Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes.
Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302
Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer. Diabetes Care August 1999 22:1292-1295; doi:10.2337/diacare.22.8.1292
Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371
Muscle fiber characteristics in postmenopausal women with normal or impaired glucose tolerance. Diabetes Care August 1999 22:1330-1338; doi:10.2337/diacare.22.8.1330
Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation.
Humalog Mix25 Study Group. Diabetes Care August 1999 22:1258-1261; doi:10.2337/diacare.22.8.1258
Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care August 1999 22:1325-1329; doi:10.2337/diacare.22.8.1325
Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized
controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296
Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318
Role of early fundoscopy for diagnosis of Wolfram syndrome in type 1 diabetic patients. Diabetes Care August 1999 22:1376-1378; doi:10.2337/diacare.22.8.1376a
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care August 1999 22:1245-1251; doi:10.2337/diacare.22.8.1245
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized
controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296
Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care August 1999 22:1266-1272; doi:10.2337/diacare.22.8.1266
Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care August 1999 22:1371-1372; doi:10.2337/diacare.22.8.1371
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes Care August 1999 22:1310-1317; doi:10.2337/diacare.22.8.1310
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347
Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer. Diabetes Care August 1999 22:1292-1295; doi:10.2337/diacare.22.8.1292
Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care August 1999 22:1284-1291; doi:10.2337/diacare.22.8.1284
Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care August 1999 22:1347-1353; doi:10.2337/diacare.22.8.1347
Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro
insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374
Late-onset lipoatrophic diabetes. Phenotypic and genotypic familial studies and effect of treatment with metformin and lispro
insulin analog. Diabetes Care August 1999 22:1374-1376; doi:10.2337/diacare.22.8.1374
Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care August 1999 22:1284-1291; doi:10.2337/diacare.22.8.1284
Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care August 1999 22:1266-1272; doi:10.2337/diacare.22.8.1266
Early identification of diabetic foot ulcers that may require intervention using the micro lightguide spectrophotometer. Diabetes Care August 1999 22:1292-1295; doi:10.2337/diacare.22.8.1292
Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes.
Diabetes Care August 1999 22:1302-1309; doi:10.2337/diacare.22.8.1302
Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care August 1999 22:1318-1324; doi:10.2337/diacare.22.8.1318
Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with
normal glucose tolerance from the Bruneck Study. Diabetes Care August 1999 22:1339-1346; doi:10.2337/diacare.22.8.1339
Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care August 1999 22:1262-1265; doi:10.2337/diacare.22.8.1262
Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation.
Humalog Mix25 Study Group. Diabetes Care August 1999 22:1258-1261; doi:10.2337/diacare.22.8.1258
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized
controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care August 1999 22:1296-1301; doi:10.2337/diacare.22.8.1296